Robert Young Kim - 07 Feb 2024 Form 3/A Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Role
Chief Medical Officer
Signature
/s/ Scott Bizily, Attorney-in-Fact for Robert Kim
Issuer symbol
FDMT
Transactions as of
07 Feb 2024
Net transactions value
$0
Form type
3/A
Filing time
07 Feb 2024, 19:42:57 UTC
Date Of Original Report
05 Apr 2023
Previous filing
07 Feb 2024
Next filing
10 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding FDMT Common Stock 1,595 07 Feb 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Form 3 for the Reporting Person, filed on April 5, 2023 (the "Original Form 3"), is being amended to report common stock held by the reporting person that was acquired prior to the filing of the Original Form 3 and that was inadvertently excluded.